Escitalopram: a unique mechanism of action.

@article{Brstrup2004EscitalopramAU,
  title={Escitalopram: a unique mechanism of action.},
  author={Claus Br{\ae}strup and Connie S{\'a}nchez},
  journal={International journal of psychiatry in clinical practice},
  year={2004},
  volume={8 Suppl 1},
  pages={11-3}
}
The 5-HT (5-hydroxytryptamine, serotonin) transporter (SERT) mediates the reuptake of 5-HT from the synaptic cleft into the neuron, and inhibition of this uptake is the target of selective serotonin reuptake inhibitors (SSRIs). Escitalopram (S-citalopram) is the most selective SSRI available, whereas the other enantiomer, R-citalopram, is approximately 30-40 times less potent than the S-enantiomer. Both biochemical experiments (measurement of extracellular 5-HT in the frontal cortex of rats… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

The importance of long-term tolerability in achieving recovery.

International journal of psychiatry in clinical practice • 2006
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-7 of 7 references

Similar Papers

Loading similar papers…